EP 1041997 A2 20001011 - USE OF CITRULLINE PEPTIDES DERIVED FROM FILAGGRIN FOR TREATING AUTOIMMUNE DISEASES
Title (en)
USE OF CITRULLINE PEPTIDES DERIVED FROM FILAGGRIN FOR TREATING AUTOIMMUNE DISEASES
Title (de)
VERWENDUNG VON CITRULLIN ENTHALTENDEN PEPTIDEN, DIE VON FILAGGRIN ABSTAMMEN, ZUR BEHANDLUNG VON AUTOIMMUNKRANKHEITEN
Title (fr)
UTILISATION DE PEPTIDES CITRULLINES DERIVES DE LA FILAGGRINE DANS LE CADRE DU TRAITEMENT DE MALADIES AUTOIMMUNES
Publication
Application
Priority
- FR 9802900 W 19981229
- FR 9716672 A 19971230
Abstract (en)
[origin: WO9934819A3] The invention concerns the use of a citrulline peptide antigen derived from filaggrin to obtain medicines for treating rheumatoid arthritis.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); A61P 29/00 (2018.01); A61P 37/00 (2018.01); C07K 14/4713 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB IE IT LI NL SE
DOCDB simple family (publication)
FR 2773078 A1 19990702; FR 2773078 B1 20000526; AT E237345 T1 20030515; AU 1971899 A 19990726; CA 2315294 A1 19990715; CA 2315294 C 20120703; DE 69813620 D1 20030522; DE 69813620 T2 20040212; DK 1041997 T3 20030804; EP 1041997 A2 20001011; EP 1041997 B1 20030416; ES 2193601 T3 20031101; JP 2002500195 A 20020108; JP 4557421 B2 20101006; WO 9934819 A2 19990715; WO 9934819 A3 19991104
DOCDB simple family (application)
FR 9716672 A 19971230; AT 98964537 T 19981229; AU 1971899 A 19981229; CA 2315294 A 19981229; DE 69813620 T 19981229; DK 98964537 T 19981229; EP 98964537 A 19981229; ES 98964537 T 19981229; FR 9802900 W 19981229; JP 2000527267 A 19981229